This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
F

ASCO® 2024 Insights: "ARMANI Trial - Ramucirumab + Paclitaxel as Switch Maintenance vs. Continuation of Oxaliplatin-Based Chemo in Patients With Advanced HER2- GC/GEJC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Filippo Pietrantonio
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Filippo Pietrantonio
88 views
June 10, 2024

Chapters

ARMANI Trial Overview & Objectives

00:00

Results: PFS, OS & Safety Profile

02:24

0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GI Videos

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatell…

Feat. A. Bullock
12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
View All

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
09:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…

Feat. Y. Janjigian, S. Cytryn, S. Maron
22:49
Integrity CE

Recent Updates in Upper Gl Cancers

Feat. S. Mukherjee
13:47
Aditya Shreenivas

Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…

Feat. S. Chakrabarti
07:35
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…

Feat. R. Kim, R. Mehta
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
09:42
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…

Feat. R. Kim, R. Mehta
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

09:58
Elizabeth Smyth

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Feat. R. Sundar
15:35
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

Overview of Esophageal & Gastric Cancer Diagnosis & Staging

Feat. V. Shankaran
15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott
10:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…

Feat. A. Zaanan